Neutrophils as a Protagonist and Target in Chronic Rhinosinusitis

키워드

참고문헌 (105)

1. Fokkens WJ, "EPOS 2012 : European position paper on rhinosinusitis and nasal polyps 2012 : a summary for otorhinolaryngologists", Rhinology, 50(1), pp.1~12 (2012)
2. Schleimer RP, "Immunopathogenesis of chronic rhinosinusitis and nasal polyposis", Annu Rev Pathol, 12(1), pp.331~357 (2017)
3. Bachert C, "Current and future treatment options for adult chronic rhinosinusitis : focus on nasal polyposis", J Allergy Clin Immunol, 136(6), pp.1431~1440 (2015)
4. Wang X, "Diversity of TH cytokine profiles in patients with chronic rhinosinusitis : a multicenter study in Europe, Asia, and Oceania", J Allergy Clin Immunol, 138(5), pp.1344~1353 (2016)
5. Huvenne W, "Chronic rhinosinusitis with and without nasal polyps: what is the difference?", Curr Allergy Asthma Rep, 9(3), pp.213~220 (2009)
6. Wang H, "The activation and function of IL-36γ in neutrophilic inflammation in chronic rhinosinusitis", J Allergy Clin Immunol, 141(5), pp.1646~1658 (2018)
7. Cao PP, "Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese", J Allergy Clin Immunol, 124(3), pp.478~484 (2009)
8. Zhang Y, "Chronic rhinosinusitis in Asia", J Allergy Clin Immunol, 140(5), pp.1230~1239 (2017)
9. Fan Y, "A lower prevalence of asthma among patients with chronic rhinosinusitis in southern China", J Allergy Clin Immunol, 127(2), pp.520~522 (2011)
10. Zhang N, "Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease", J Allergy Clin Immunol, 122(5), pp.961~968 (2008)
11. Cao PP, "Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes", Ann Allergy Asthma Immunol, 122(1), pp.33~40 (2019)
12. Cao PP, "Increased local IgE production induced by common aeroallergens and phenotypic alteration of mast cells in Chinese eosinophilic, but not noneosinophilic, chronic rhinosinusitis with nasal polyps", Clin Exp Allergy, 44(5), pp.690~700 (2014)
13. Payne SC, "Evidence for distinct histologic profile of nasal polyps with and without eosinophilia", Laryngoscope, 121(10), pp.2262~2267 (2011)
14. Kim DK, "Noneosinophilic nasal polyps shows increased epithelial proliferation and localized disease pattern in the early stage", PLoS One, 10(10), pp.e0139945~ (2015)
15. Shi LL, "Disease-specific T-helper cell polarizing function of lesional dendritic cells in different types of chronic rhinosinusitis with nasal polyps", Am J Respir Crit Care Med, 190(6), pp.628~638 (2014)
16. Shi LL, "Features of airway remodeling in different types of Chinese chronic rhinosinusitis are associated with inflammation patterns", Allergy, 68(1), pp.101~109 (2013)
17. Ma J, "CD8(+)T cells with distinct cytokine-producing features and low cytotoxic activity in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps", Clin Exp Allergy, 46(9), pp.1162~1175 (2016)
18. Pothoven KL, "Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease", J Allergy Clin Immunol, 139(6), pp.1966~1978 (2016)[DOI]
19. Bachert C, "Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma", J Allergy Clin Immunol, 126(5), pp.962~968 (2010)[DOI]
20. Tomassen P, "Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers", J Allergy Clin Immunol, 137(5), pp.1449e4~1456e4 (2016)
21. Wen W, "Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy", J Allergy Clin Immunol, 129(6), pp.1522e5~1528e5 (2012)
22. Liao B, "Multidimensional endotypes of chronic rhinosinusitis and their association with treatment outcomes", Allergy, 73(7), pp.1459~1469 (2018)
23. Soehnlein O, "Neutrophils as protagonists and targets in chronic inflammation", Nat Rev Immunol, 17(4), pp.248~261 (2017)
24. Coffelt SB, "Neutrophils in cancer : neutral no more", Nat Rev Cancer, 16(7), pp.431~446 (2016)
25. Ley K, "Neutrophils: new insights and open questions", Sci Immunol, 3(30), pp.eaat4579~ (2018)
26. de Oliveira S, "Neutrophil migration in infection and wound repair : going forward in reverse", Nat Rev Immunol, 16(6), pp.378~391 (2016)
27. Shiozawa A, "Comparative analysis of cytokine release from epithelial cell cultures of the upper airway", Rhinology, 53(2), pp.135~141 (2015)
28. Shimizu S, "HMGB1-TLR4signaling contributes to the secretion of interleukin 6 and interleukin 8 by nasal epithelial cells", Am J Rhinol Allergy, 30(3), pp.167~172 (2016)
29. Rammal A, "Differences in RANTES and IL-6levels among chronic rhinosinusitis patients with predominant gramnegative and gram-positive infection", J Otolaryngol Head Neck Surg, 46(1), pp.7~ (2017)
30. Ozturk AB, "Comparison of inflammatory cytokine release from nasal epithelial cells of non-atopic non-rhinitic, allergic rhinitic and polyp subjects and effects of diesel exhaust particles in vitro", Allergol Immunopathol(Madr), 45(5), pp.473~481 (2017)
31. Tsai YJ, "Thromboxane A2 regulates CXCL1 and CXCL8 chemokine expression in the nasal mucosaderived fibroblasts of chronic rhinosinusitis patients", PLoS One, 11(6), pp.e0158438~ (2016)
32. Shimizu S, "Thrombin and activated coagulation factor X stimulate the release of cytokines and fibronectin from nasal polyp fibroblasts via protease-activated receptors", Am J Rhinol Allergy, 31(1), pp.13~18 (2017)
33. Zhai GT, "IgD-activated mast cells induce IgE synthesis in B cells in nasal polyps", J Allergy Clin Immunol, 142(5), pp.1489.e23~1499.e23 (2018)
34. Van Zele T, "Differentiation of chronic sinus diseases by measurement of inflammatory mediators", Allergy, 61(11), pp.1280~1289 (2006)
35. Kim DW, "Chronic rhinosinusitis without nasal polyps in Asian patients shows mixed inflammatory patterns and neutrophil-related disease severity", Mediators Inflamm, 2019, pp.7138643~ (2019)
36. Cho DY, "Expression of dual oxidases and secreted cytokines in chronic rhinosinusitis", Int Forum Allergy Rhinol, 3(5), pp.376~383 (2013)
37. Wei B, "Multivariate analysis of inflammatory endotypes in recurrent nasal polyposis in a Chinese population", Rhinology, 56(3), pp.216~226 (2018)
38. Weaver CT, "IL-17 family cytokines and the expanding diversity of effector T cell lineages", Annu Rev Immunol, 25(1), pp.821~852 (2007)
39. Pridgeon C, "Regulation of IL-17 in chronic inflammation in the human lung", Clin Sci(Lond), 120(12), pp.515~524 (2011)
40. Niu YZ, "Effects of IL-17 on expression of GRO-α and IL-8 in fibroblasts from nasal polyps", J Huazhong Univ Sci Technolog Med Sci, 34(4), pp.591~595 (2014)
41. Wang H, "Interleukin-17A contributes to the expression of serum amyloid A in chronic rhinosinusitis with nasal polyps", Eur Arch Otorhinolaryngol, 270(6), pp.1867~1872 (2013)
42. Saitoh T, "Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma", Int Arch Allergy Immunol, 151(1), pp.8~16 (2010)
43. Makihara S, "Regulation and characterization of IL-17A expression in patients with chronic rhinosinusitis and its relationship with eosinophilic inflammation", J Allergy Clin Immunol, 126(2), pp.397~400 (2010)
44. Wakashin H, "IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice", Am J Respir Crit Care Med, 178(10), pp.1023~1032 (2008)
45. Jeanson L, "Oxidative stress induces unfolding protein response and inflammation in nasal polyposis", Allergy, 67(3), pp.403~412 (2012)
46. Liew PX, "The neutrophil’s role during health and disease", Physiol Rev, 99(2), pp.1223~1248 (2019)
47. Hamilos DL, "Host-microbial interactions in patients with chronic rhinosinusitis", J Allergy Clin Immunol, 133(3), pp.640.e4~653.e4 (2014)
48. Mahdavinia M, "A comprehensive review of the nasal microbiome in chronic rhinosinusitis(CRS)", Clin Exp Allergy, 46(1), pp.21~41 (2016)
49. Dobretsov K, "The theory of a “staphylococcus superantigen” in chronic rhinosinusitis with nasal polyps:myth or reality?", Eur Rev Med Pharmacol Sci, 23(1 Suppl), pp.48~54 (2019)
50. Mahdavinia M, "The nasal microbiome in patients with chronic rhinosinusitis : analyzing the effects of atopy and bacterial functional pathways in 111 patients", J Allergy Clin Immunol, 142(1), pp.287~290 (2018)
51. Sanclement JA, "Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis", Laryngoscope, 115(4), pp.578~582 (2005)
52. Donlan RM, "Biofilms : survival mechanisms of clinically relevant microorganisms", Clin Microbiol Rev, 15(2), pp.167~193 (2002)
53. Galli J, "Damage to ciliated epithelium in chronic rhinosinusitis: what is the role of bacterial biofilms?", Ann Otol Rhinol Laryngol, 117(12), pp.902~908 (2008)
54. Wang X, "Bacterial biofilms are associated with inflammatory cells infiltration and the innate immunity in chronic rhinosinusitis with or without nasal polyps", Inflammation, 37(3), pp.871~879 (2014)
55. Dale DC, "The phagocytes : neutrophils and monocytes", Blood, 112(4), pp.935~945 (2008)
56. Segal AW, "How neutrophils kill microbes", Annu Rev Immunol, 23(1), pp.197~223 (2005)
57. Nasser A, "Staphylococcus aureus versus neutrophil : scrutiny of ancient combat", Microb Pathog, 131, pp.259~269 (2019)
58. Chen Y, "TLR2 agonist Pam3CSK4 enhances the antibacterial functions of GM-CSF induced neutrophils to methicillin-resistant Staphylococcus aureus", Microb Pathog, 130, pp.204~212 (2019)
59. Grunwell JR, "Children with neutrophil-predominant severe asthma have proinflammatory neutrophils with enhanced survival and impaired clearance", J Allergy Clin Immunol. Pract, 7(2), pp.516~525 (2019)
60. Sheshachalam A, "Granule protein processing and regulated secretion in neutrophils", Front Immunol, 5, pp.448~ (2014)
61. Korkmaz B, "Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases", Pharmacol Rev, 62(4), pp.726~759 (2010)
62. Clancy DM, "Extracellular neutrophil proteases are efficient regulators of IL-1, IL-33, and IL-36 cytokine activity but poor effectors of microbial killing", Cell Rep, 22(11), pp.2937~2950 (2018)
63. Papayannopoulos V, "Neutrophil extracellular traps in immunity and disease", Nat Rev Immunol, 18(2), pp.134~147 (2018)
64. Castanheira FV, "Neutrophils and NETs in modulating acute and chronic inflammation", Blood, 133(20), pp.2178~2185 (2019)
65. Branzk N, "Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens", Nat Immunol, 15(11), pp.1017~1025 (2014)
66. Goodridge HS, "Activation of the innate immune receptor Dectin-1 upon formation of a ‘phagocytic synapse’", Nature, 472(7344), pp.471~475 (2011)
67. McDonald B, "Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis", Cell Host Microbe, 12(3), pp.324~333 (2012)
68. Wright TK, "Neutrophil extracellular traps are associated with inflammation in chronic airway disease", Respirology, 21(3), pp.467~475 (2016)
69. Cao Y, "LL-37 promotes neutrophil extracellular trap formation in chronic rhinosinusitis with nasal polyps", Clin Exp Allergy, 49(7), pp.990~999 (2019)
70. Tan BK, "Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps", J Allergy Clin Immunol, 128(6), pp.1198~1206 (2011)
71. Thery C, "Membrane vesicles as conveyors of immune responses", Nat Rev Immunol, 9(8), pp.581~593 (2009)
72. 홍장원, "Extracellular Vesicles of Neutrophils", Immune Network, 18(6), pp.1~9 (2018), 대한면역학회[DOI]
73. Dalli J, "Heterogeneity in neutrophil microparticles reveals distinct proteome and functional properties", Mol Cell Proteomics, 12(8), pp.2205~2219 (2013)
74. Lim K, "Neutrophil trails guide influenza-specific CD8+ T cells in the airways", Science, 349(6252), pp.aaa4352~ (2015)
75. Hess C, "Ectosomes released by human neutrophils are specialized functional units", J Immunol, 163(8), pp.4564~4573 (1999)
76. Prakash PS, "Human microparticles generated during sepsis in patients with critical illness are neutrophil-derived and modulate the immune response", J Trauma Acute Care Surg, 73(2), pp.401~406 (2012)
77. Genschmer KR, "Activated PMN exosomes : pathogenic entities causing matrix destruction and disease in the lung", Cell, 176, pp.113~126 (2019)
78. Mantovani A, "Neutrophils in the activation and regulation of innate and adaptive immunity", Nat Rev Immunol, 11(8), pp.519~531 (2011)
79. Platanias LC, "Mechanisms of type-I-and type-II-interferon-mediated signalling", Nat Rev Immunol, 5(5), pp.375~386 (2005)
80. Wang BF, "Interferon-γ-induced insufficient autophagy contributes to p62-dependent apoptosis of epithelial cells in chronic rhinosinusitis with nasal polyps", Allergy, 72(9), pp.1384~1397 (2017)
81. Lee M, "The IFN-γ-p38, ERK kinase axis exacerbates neutrophilic chronic rhinosinusitis by inducing the epithelial-to-mesenchymal transition", Mucosal Immunol, 12(3), pp.601~611 (2019)
82. Sun B, "Characterization and allergic role of IL-33-induced neutrophil polarization", Cell Mol Immunol, 15(8), pp.782~793 (2018)
83. Petersen BC, "Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology", Nat Med, 18(5), pp.751~758 (2012)
84. Ma Y, "Temporal neutrophil polarization following myocardial infarction", Cardiovasc Res, 110(1), pp.51~61 (2016)
85. Martin SJ, "Cell death and inflammation : the case for IL-1 family cytokines as the canonical DAMPs of the immune system", FEBS J, 283(14), pp.2599~2615 (2016)
86. 김동규, "Comparison Between Signature Cytokines of Nasal Tissues in Subtypes of Chronic Rhinosinusitis", Allergy, Asthma & Immunology Research, 11(2), pp.201~211 (2019), 대한천식알레르기학회
87. Cayrol C, "Interleukin-33(IL-33) : a nuclear cytokine from the IL-1 family", Immunol Rev, 281(1), pp.154~168 (2018)
88. Hueber AJ, "IL-33 induces skin inflammation with mast cell and neutrophil activation", Eur J Immunol, 41(8), pp.2229~2237 (2011)
89. Alves-Filho JC, "Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection", Nat Med, 16(6), pp.708~712 (2010)
90. Kim DK, "The role of interleukin-33 in chronic rhinosinusitis", Thorax, 72(7), pp.635~645 (2017)
91. Liao B, "Interaction of thymic stromal lymphopoietin, IL-33, and their receptors in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polyps", Allergy, 70(9), pp.1169~1180 (2015)
92. Baba S, "Expression of IL-33 and its receptor ST2 in chronic rhinosinusitis with nasal polyps", Laryngoscope, 124(4), pp.E115~E22 (2014)
93. Kim DW, "Age-related decline of neutrophilic inflammation is associated with better postoperative prognosis in non-eosinophilic nasal polyps", PLoS One, 11(2), pp.e0148442~ (2016)
94. Morse JC, "Chronic rhinosinusitis in elderly patients is associated with an exaggerated neutrophilic proinflammatory response to pathogenic bacteria", J Allergy Clin Immunol, 143(3), pp.990~1002 (2019)
95. Cho SH, "Age-related differences in the pathogenesis of chronic rhinosinusitis", J Allergy Clin Immunol, 129(3), pp.858~860 (2012)
96. Cox G, "Glucocorticoid treatment inhibits apoptosis in human neutrophils : separation of survival and activation outcomes", J Immunol, 154(9), pp.4719~4725 (1995)
97. Tamaoki J, "The effects of macrolides on inflammatory cells", Chest, 125(2 Suppl), pp.41S~50S (2004)
98. Tauber SC, "Immunomodulatory properties of antibiotics", Curr Mol Pharmacol, 1(1), pp.68~79 (2008)
99. Luo Q, "Evaluation of long-term clarithromycin treatment in adult Chinese patients with chronic rhinosinusitis without nasal polyps", ORL J Otorhinolaryngol Relat Spec, 73(4), pp.206~211 (2011)
100. Wallwork B, "A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis", Laryngoscope, 116(2), pp.189~193 (2006)
101. Videler WJ, "Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis : a randomized controlled trial", Allergy, 66(11), pp.1457~1468 (2011)
102. Rennard SI, "CXCR2 antagonist MK-7123 : a phase 2 proof-of-concept trial for chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 191(9), pp.1001~1011 (2015)
103. Todd CM, "The effects of a CXCR1", CXCR2 antagonist on neutrophil migration in mild atopic asthmatic subjects, 2016, pp.41, 34~39
104. Dalli J, "Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents", Chem Biol, 20(2), pp.188~201 (2013)
105. Natsis NE, "Bimekizumab for the treatment of psoriatic disease", Expert Opin Biol Ther, 18(12), pp.1193~1197 (2018)

관련 논문AI추천